LB1_12

General Information


DRACP ID  DRACP05384

Peptide Name   LB1_12

Sequence  EXREXRILFQYEXREXR

Sequence Length  17

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides Membrane-targeted Cell-penetrating peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  N-terminal alkyne is introduced using 4-pentynoic acid

C-terminal Modification  Amidation

Other Modification  X=aminohexyl residue

Chiral  L



Physicochemical Information


Formula  C79H118N26O20

Absent amino acids  ACDGHKMNPSTVW

Common amino acids  ERX

Mass  247751

Pl  6.66

Basic residues  4

Acidic residues  4

Hydrophobic residues  3

Net charge  0

Boman Index  -7978

Hydrophobicity  -151.18

Aliphatic Index  45.88

Half Life 
  /

Extinction Coefficient cystines  1490

Absorbance 280nm  93.13

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 24105028

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




Cppsite ID  2115

DRACP is developed by Dr.Zheng's team.